110 related articles for article (PubMed ID: 6688845)
21. European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.
Wilder RB; Schlembach PJ; Jones D; Chronowski GM; Ha CS; Younes A; Hagemeister FB; Barista I; Cabanillas F; Cox JD
Cancer; 2002 Mar; 94(6):1731-8. PubMed ID: 11920535
[TBL] [Abstract][Full Text] [Related]
22. Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials.
Hancock SL; Hoppe RT; Horning SJ; Rosenberg SA
Ann Intern Med; 1988 Aug; 109(3):183-9. PubMed ID: 3291657
[TBL] [Abstract][Full Text] [Related]
23. [Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P].
Baillet F; Brun B; Mazeron JJ; Rochant H; Pinon G; Reyes F; Vernant JP; Pierquin B; Dreyfus B
Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):457-61. PubMed ID: 917834
[TBL] [Abstract][Full Text] [Related]
24. MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients.
Moore MR; Jones SE; Bull JM; William LA; Rosenberg SA
Cancer; 1973 Jul; 32(1):52-60. PubMed ID: 4716784
[No Abstract] [Full Text] [Related]
25. [Treatment of recurrences of lymphogranulomatosis].
Kovryzhkina TA
Med Radiol (Mosk); 1984 Jan; 29(1):35-9. PubMed ID: 6546406
[No Abstract] [Full Text] [Related]
26. [Hodgkin's disease in childhood: long term results].
Cramer P; Schaison G; Andrieu JM; Boiron M; Bernard J
Arch Fr Pediatr; 1982 Apr; 39(4):223-9. PubMed ID: 6896975
[TBL] [Abstract][Full Text] [Related]
27. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
[TBL] [Abstract][Full Text] [Related]
28. [Effectiveness of chemotherapy and radiotherapy in 60 cases of Hodgkin's lymphoma].
Yong WB; Wang H; Zhu XM
Zhonghua Nei Ke Za Zhi; 1993 Feb; 32(2):91-3. PubMed ID: 7691489
[TBL] [Abstract][Full Text] [Related]
29. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
30. [Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)].
Lauria F; Baccarani M; Barbieri E; Fiacchini M; Gobbi M; Tura S; Baccarani M
Haematologica; 1975 Mar; 60(1):73-84. PubMed ID: 806500
[No Abstract] [Full Text] [Related]
31. Radiotherapy versus radiotherapy plus chemotherapy in stages I and II Hodgkin's disease. A prospective, randomized study by the Danish National Hodgkin Study Group, LYGRA.
Nissen NI; Nordentoft AM; Brincker H; Andersen E; Jensen MK; Nielsen JB; Pedersen-Bjergaard J; Jensen TS; Jensen KB; Videbaek A; Pedersen M; Walbom-Jørgensen S
Scand J Haematol; 1980 Jul; 25(1):35-44. PubMed ID: 7003700
[TBL] [Abstract][Full Text] [Related]
32. A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
Huguley CM; Durant JR; Moores RR; Chan YK; Dorfman RF; Johnson L
Cancer; 1975 Oct; 36(4):1227-40. PubMed ID: 1175125
[TBL] [Abstract][Full Text] [Related]
33. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of lymphogranulomatosis].
Baĭsogolov GD
Med Radiol (Mosk); 1982 Sep; 27(9):83-9. PubMed ID: 6897278
[No Abstract] [Full Text] [Related]
35. [Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow].
Fiacchini M; Lauria F; Mazza P; Tura S
Haematologica; 1982 Jun; 67(3):394-401. PubMed ID: 6814996
[No Abstract] [Full Text] [Related]
36. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
37. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
38. Treatment of stage I and II mediastinal Hodgkin disease. A comparison of involved fields, extended fields, and involved fields followed by MOPP in patients staged by laparotomy.
Hagemeister FB; Fuller LM; Sullivan JA; North L; Velasquez W; Conrad FG; McLaughlin P; Butler JJ; Shullenberger CC
Radiology; 1981 Dec; 141(3):783-9. PubMed ID: 6895415
[TBL] [Abstract][Full Text] [Related]
39. [Drug therapy of Hodgkin's disease].
Gallmeier WM; Bruntsch U
Internist (Berl); 1981 May; 22(5):289-300. PubMed ID: 7019138
[No Abstract] [Full Text] [Related]
40. Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of Cancer.
Carde P; Hayat M; Cosset JM; Somers R; Burgers JM; Sizoo W; Meerwaldt JH; Hagenbeek A; Monconduit M; van der Schueren E
NCI Monogr; 1988; (6):303-10. PubMed ID: 3352775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
